599 related articles for article (PubMed ID: 15610663)
1. Current status of vaccination therapy for leukemias.
Reichardt VL; Brossart P
Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663
[TBL] [Abstract][Full Text] [Related]
2. DC-based immunotherapy of B-cell malignancies.
Reichardt VL; Brossart P
Cytotherapy; 2004; 6(1):62-7. PubMed ID: 14985168
[TBL] [Abstract][Full Text] [Related]
3. The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML.
Redaelli A; Stephens JM; Laskin BL; Pashos CL; Botteman MF
Expert Rev Anticancer Ther; 2003 Jun; 3(3):311-29. PubMed ID: 12820775
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell vaccines for leukemia patients.
Schmitt A; Hus I; Schmitt M
Expert Rev Anticancer Ther; 2007 Mar; 7(3):275-83. PubMed ID: 17338648
[TBL] [Abstract][Full Text] [Related]
5. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1994; 15():391-412. PubMed ID: 7779590
[No Abstract] [Full Text] [Related]
6. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
[No Abstract] [Full Text] [Related]
7. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
8. [Treatment of acute and chronic leukemias].
Mandelli F; Montefusco E
Recenti Prog Med; 1999 Nov; 90(11):605-12. PubMed ID: 10608151
[TBL] [Abstract][Full Text] [Related]
9. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
[No Abstract] [Full Text] [Related]
10. Vaccination for leukemia.
Molldrem JJ
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):13-8. PubMed ID: 16399579
[TBL] [Abstract][Full Text] [Related]
11. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
12. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
[No Abstract] [Full Text] [Related]
13. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
Le Dieu R; Gribben J
Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
[TBL] [Abstract][Full Text] [Related]
14. Treatment of childhood leukemias.
Pui CH; Crist WM
Curr Opin Oncol; 1995 Jan; 7(1):36-44. PubMed ID: 7696362
[TBL] [Abstract][Full Text] [Related]
15. Current thinking in the management of leukaemia.
Szer J
Aust Fam Physician; 1994 Aug; 23(8):1500-5. PubMed ID: 7526835
[TBL] [Abstract][Full Text] [Related]
16. [Promise of immunotherapy of the chronic myeloid leukaemia].
Vonka V
Cas Lek Cesk; 2005; 144(3):172-6. PubMed ID: 15887400
[TBL] [Abstract][Full Text] [Related]
17. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1996; 16():347-75. PubMed ID: 8639390
[No Abstract] [Full Text] [Related]
18. Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST).
Heinzelmann F; Ottinger H; Müller CH; Allgaier S; Faul C; Bamberg M; Belka C
Strahlenther Onkol; 2006 Apr; 182(4):222-30. PubMed ID: 16622624
[TBL] [Abstract][Full Text] [Related]
19. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
20. Immunogenic antigens as therapeutic targets against myeloid leukaemic cells.
Hofmann S; Greiner J
Leuk Res; 2010 Jul; 34(7):850-1. PubMed ID: 20359745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]